Variant report
Variant | esv3330452 |
---|---|
Chromosome Location | chr13:64084000-64114816 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9564070 | chr13:64086204-64086205 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs532496580 | chr13:64086209-64086210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs58456442 | chr13:64086256-64086257 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs116436267 | chr13:64086263-64086264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536224543 | chr13:64086267-64086268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs207473893 | chr13:64086313-64086314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs9570930 | chr13:64086320-64086321 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs114242837 | chr13:64086325-64086326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534894540 | chr13:64086354-64086355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553102526 | chr13:64086445-64086446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577811512 | chr13:64086464-64086465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs151095113 | chr13:64086487-64086488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs9528649 | chr13:64086510-64086511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200817708 | chr13:64086531-64086532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192052415 | chr13:64086545-64086546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542979350 | chr13:64086564-64086565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561241036 | chr13:64086565-64086566 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573242342 | chr13:64086574-64086575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9528650 | chr13:64086575-64086576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144153965 | chr13:64086581-64086582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs534724052 | chr13:64088015-64088016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200596209 | chr13:64088034-64088035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs60409923 | chr13:64088037-64088038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs117540313 | chr13:64088085-64088086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564315361 | chr13:64088099-64088100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574535130 | chr13:64088103-64088104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576324889 | chr13:64088113-64088114 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143418690 | chr13:64088115-64088116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35409792 | chr13:64088116-64088117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs527310563 | chr13:64088122-64088123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs200037422 | chr13:64088200-64088201 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545357795 | chr13:64088245-64088246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs563847954 | chr13:64088284-64088285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs181647008 | chr13:64088319-64088320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145558218 | chr13:64088365-64088366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs148858459 | chr13:64088501-64088502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs11838617 | chr13:64088509-64088510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548887384 | chr13:64088516-64088517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567137785 | chr13:64088553-64088554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143484399 | chr13:64088623-64088624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs117344320 | chr13:64088642-64088643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150935865 | chr13:64088694-64088695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141921744 | chr13:64088720-64088721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs146905554 | chr13:64088724-64088725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556364538 | chr13:64088735-64088736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186655989 | chr13:64088740-64088741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs626742 | chr13:64088820-64088821 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs17356254 | chr13:64088848-64088849 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs571967982 | chr13:64088849-64088850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs114873009 | chr13:64088891-64088892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:64086200-64086600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr13:64088000-64088200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr13:64088200-64089200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr13:64089200-64089600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr13:64091200-64091800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr13:64091400-64091800 | Enhancers | Osteobl | bone |
7 | chr13:64091400-64092000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr13:64091400-64092000 | Enhancers | Fetal Lung | lung |
9 | chr13:64091600-64091800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr13:64092200-64092800 | Enhancers | HUVEC | blood vessel |
11 | chr13:64098200-64098400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr13:64098600-64099000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr13:64100000-64101600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr13:64101600-64101800 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr13:64101600-64101800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr13:64101800-64105000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr13:64105200-64105400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr13:64112600-64114200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
19 | chr13:64114200-64117200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |